pubmed.ncbi.nlm.nih.gov

Crystallization and preliminary crystallographic studies of human RIG-I in complex with double-stranded RNA - PubMed

  • ️Thu Jan 01 2009

Crystallization and preliminary crystallographic studies of human RIG-I in complex with double-stranded RNA

Hyunjin Moon et al. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009.

Abstract

Retinoic acid inducible gene-I (RIG-I) is an essential component of the innate immune system that is responsible for the detection and elimination of invading viruses. RIG-I recognizes viral RNAs inside the cell and then initiates downstream signalling to activate the IRF-3 and NF-kappaB genes, which results in the production of type I interferons. RIG-I is composed of an N-terminal CARD domain for signalling and C-terminal helicase and repressor domains for RNA recognition. A RIG-I-RNA binding assay was performed to investigate the in vitro RIG-I-RNA binding properties. Selenomethionine-incorporated RIG-I was expressed using Escherichia coli and purified for crystallization. X-ray data were collected from RIG-I-dsRNA complex crystals to 2.8 A resolution using synchrotron radiation.

PubMed Disclaimer

Figures

Figure 1
Figure 1

Crystals of human RIG-I (218–925)–18-mer dsRNA complex.

Figure 2
Figure 2

Human RIG-I (218–925)–18-mer dsRNA binding assay at pH 7.0 using an electrophoretic mobility shift assay. Human RIG-I proteins were mixed with 18-­mer dsRNA in 100 mM HEPES pH 7.0. After incubation at room teperature for 20 min, the mixture was applied onto a 15% TBE–polyacrylamide gel and stained with ethidium bromide. The lanes are 1 kb DNA marker, 18-mer dsRNA, RIG-I protein and 18-mer dsRNA and RIG-I mixtures with RIG-I:dsRNA molar ratios of 0.12, 0.25, 0.5, 1, 2 and 4, respectively.

Similar articles

Cited by

References

    1. Cui, S., Eisenacher, K., Kirchhofer, A., Brzozka, K., Lammens, A., Lammens, K., Fujita, T., Conzelmann, K. K., Krug, A. & Hopfner, K. P. (2008). Mol. Cell, 29, 169–179. - PubMed
    1. Heim, M. H. (2005). J. Hepatol.42, 431–433. - PubMed
    1. Hornung, V., Ellegast, J., Kim, S., Brzozka, K., Jung, A., Kato, H., Poeck, H., Akira, S., Conzelmann, K. K., Schlee, M., Endres, S. & Hartmann, G. (2006). Science, 314, 994–997. - PubMed
    1. Kato, H., Takeuchi, O., Mikamo-Satoh, E., Hirai, R., Kawai, T., Matsushita, K., Hiiragi, A., Dermody, T. S., Fujita, T. & Akira, S. (2008). J. Exp. Med.205, 1601–1610. - PMC - PubMed
    1. Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K. J., Takeuchi, O. & Akira, S. (2005). Nature Immunol.6, 981–988. - PubMed

Publication types

MeSH terms

Substances